Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

CSL Limited (ASX:CSL)

Pharmaceuticals, Biotechnology & Life Sciences

CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.

CSL Limited (ASX:CSL) share price

CSL Limited (ASX:CSL) share price news

australiansuper-fees-Australian-Super-question-doubt-idea
ASX Share Ideas
Max Wagner

Can Cochlear (COH) Shares Reach $220 Again?

The 52-week high price for Cochlear Limited (ASX: COH) shares is $221.44. Up almost 20% in the last three months, could Cochlear reach these highs again?

estia-share-price-image-Mature woman holds her heart. Woman having a pain in the heart area. Heart Attack. Painful Chest. Health Care, Medical Concept. High Resolution.
ASX Share Ideas
Rask Invest Research Team

Should The CSL Share Price Be $205?

You would think CSL Limited (ASX:CSL) shares had done enough for ASX investors,  rising from $30 in 2011 to over $190 today. Can the CSL share price go higher?

Skip to content